Sidell KR - Search Results

1

Elevated CSF prostaglandin E2 levels in patients with probable AD.

Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ 2nd, Morrow JD. Montine TJ, et al. Among authors: sidell kr. Neurology. 1999 Oct 22;53(7):1495-8. doi: 10.1212/wnl.53.7.1495. Neurology. 1999. PMID: 10534257

2

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: sidell kr. J Neuropathol Exp Neurol. 1998 May;57(5):415-25. doi: 10.1097/00005072-199805000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9596412

3

Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis.

Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ 2nd, Dermody TS, Morrow JD, Montine TJ. Valyi-Nagy T, et al. Among authors: sidell kr. J Neuropathol Exp Neurol. 1999 Dec;58(12):1269-75. doi: 10.1097/00005072-199912000-00008. J Neuropathol Exp Neurol. 1999. PMID: 10604752

4

Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum.

Sidell KR, Montine KS, Picklo MJ Sr, Olsen SJ, Amarnath V, Montine TJ. Sidell KR, et al. J Neuropathol Exp Neurol. 2003 Feb;62(2):146-53. doi: 10.1093/jnen/62.2.146. J Neuropathol Exp Neurol. 2003. PMID: 12578224

5

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

Neely MD, Sidell KR, Graham DG, Montine TJ. Neely MD, et al. Among authors: sidell kr. J Neurochem. 1999 Jun;72(6):2323-33. doi: 10.1046/j.1471-4159.1999.0722323.x. J Neurochem. 1999. PMID: 10349841 Free article.

6

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Bassett CN, et al. Among authors: sidell kr. Lipids. 1999 Dec;34(12):1273-80. doi: 10.1007/s11745-999-0478-1. Lipids. 1999. PMID: 10652986

7

Dopamine mercapturate can augment dopaminergic neurodegeneration.

Montine TJ, Amarnath V, Picklo MJ, Sidell KR, Zhang J, Graham DG. Montine TJ, et al. Among authors: sidell kr. Drug Metab Rev. 2000 Aug-Nov;32(3-4):363-76. doi: 10.1081/dmr-100102339. Drug Metab Rev. 2000. PMID: 11139134 Review.

8

Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo.

Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Sidell KR, et al. J Neurochem. 2001 Nov;79(3):510-21. doi: 10.1046/j.1471-4159.2001.00586.x. J Neurochem. 2001. PMID: 11701754 Free article.

9

Dopamine thioethers in neurodegeneration.

Sidell KR, Amamath V, Montine TJ. Sidell KR, et al. Curr Top Med Chem. 2001 Dec;1(6):519-27. doi: 10.2174/1568026013394705. Curr Top Med Chem. 2001. PMID: 11895128 Review.

10

Dopamine thioethers: formation in brain and neurotoxicity.

Montine KS, Sidell KR, Zhang J, Montine TJ. Montine KS, et al. Among authors: sidell kr. Neurotox Res. 2002 Nov-Dec;4(7-8):663-669. doi: 10.1080/1029842021000045435. Neurotox Res. 2002. PMID: 12709304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters